{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:45:38Z","timestamp":1791395138800,"version":"4.3.3"},"reference-count":113,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T00:00:00Z","timestamp":1392249600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosgenetics.org"],"crossmark-restriction":false},"short-container-title":["PLoS Genet"],"DOI":"10.1371\/journal.pgen.1004135","type":"journal-article","created":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T21:52:03Z","timestamp":1392328323000},"page":"e1004135","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgen.corrections_policy","source":"Crossref","is-referenced-by-count":311,"title":["Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma"],"prefix":"10.1371","volume":"10","author":[{"given":"Mitesh J.","family":"Borad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia D.","family":"Champion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan B.","family":"Egan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie S.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan H.","family":"Bryce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann E.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maitray D.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott W.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin C.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"Condjella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R.","family":"McWilliams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos N.","family":"Lazaridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric W.","family":"Klee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith C.","family":"Bible","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin R.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaysheel D.","family":"Bhavsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha A.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Middha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Asmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Kocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Schahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin R.","family":"Kipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily G.","family":"Barr Fritcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Aldrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Kurdoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Izatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Christoforides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cherni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Nasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Reiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Adkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Mastrian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Placek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aprill T.","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"LoBello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Von Hoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Keith","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Carpten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,2,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/ije\/25.5.933","article-title":"Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea","volume":"25","author":"HR Shin","year":"1996","journal-title":"International journal of epidemiology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/bjs.1800830809","article-title":"Cholangiocarcinoma in patients with opisthorchiasis","volume":"83","author":"P Watanapa","year":"1996","journal-title":"The British journal of surgery"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1046\/j.1365-2168.2002.02143.x","article-title":"Liver fluke-associated cholangiocarcinoma","volume":"89","author":"P Watanapa","year":"2002","journal-title":"The British journal of surgery"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"A Bergquist","year":"2002","journal-title":"Journal of hepatology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.510270201","article-title":"Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study","volume":"27","author":"A Bergquist","year":"1998","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","volume":"99","author":"K Burak","year":"2004","journal-title":"The American journal of gastroenterology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","volume":"50","author":"MM Claessen","year":"2009","journal-title":"Journal of hepatology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/archsurg.139.8.855","article-title":"Congenital choledochal cysts in adults","volume":"139","author":"BC Visser","year":"2004","journal-title":"Archives of surgery"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/ijc.23251","article-title":"Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China","volume":"122","author":"AW Hsing","year":"2008","journal-title":"International journal of cancer Journal international du cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/1097-0142(20000601)88:11<2471::AID-CNCR7>3.0.CO;2-T","article-title":"Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis","volume":"88","author":"M Kobayashi","year":"2000","journal-title":"Cancer"},{"key":"ref11","first-page":"285","article-title":"Pathogenesis of cholangiocarcinoma in the porta hepatis and infection of hepatitis virus","volume":"2","author":"XF Liu","year":"2003","journal-title":"Hepatobiliary & pancreatic diseases international : HBPD INT"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1053\/j.gastro.2004.12.048","article-title":"Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study","volume":"128","author":"YH Shaib","year":"2005","journal-title":"Gastroenterology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.cgh.2007.05.020","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study","volume":"5","author":"TM Welzel","year":"2007","journal-title":"Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1349-7006.2004.tb02492.x","article-title":"Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma","volume":"95","author":"S Yamamoto","year":"2004","journal-title":"Cancer science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1023\/A:1013747228572","article-title":"Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy","volume":"12","author":"F Donato","year":"2001","journal-title":"Cancer causes & control : CCC"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1046\/j.1440-1746.2002.02779.x","article-title":"What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma?","volume":"17","author":"CC Lee","year":"2002","journal-title":"Journal of gastroenterology and hepatology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.ejca.2008.02.050","article-title":"Mortality among Thorotrast-exposed patients and an unexposed comparison group in the German Thorotrast study","volume":"44","author":"N Becker","year":"2008","journal-title":"European journal of cancer"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1667\/RR3095","article-title":"Site-specific cancer incidence and mortality after cerebral angiography with radioactive thorotrast","volume":"160","author":"LB Travis","year":"2003","journal-title":"Radiation research"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(05)67530-7","article-title":"Cholangiocarcinoma","volume":"366","author":"SA Khan","year":"2005","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"J Valle","year":"2010","journal-title":"The New England journal of medicine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/mc.2940080415","article-title":"Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand","volume":"8","author":"T Kiba","year":"1993","journal-title":"Molecular carcinogenesis"},{"key":"ref22","first-page":"305","article-title":"High rates of Ki-ras point mutation in both intra- and extra-hepatic cholangiocarcinomas","volume":"24","author":"K Ohashi","year":"1994","journal-title":"Japanese journal of clinical oncology"},{"key":"ref23","first-page":"71","article-title":"K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients","volume":"29","author":"S Petmitr","year":"1998","journal-title":"The Southeast Asian journal of tropical medicine and public health"},{"key":"ref24","first-page":"955","article-title":"[K-ras gene mutation in gallbladder carcinoma]","volume":"132","author":"JC Roa","year":"2004","journal-title":"Revista medica de Chile"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0215(19981209)78:6<695::AID-IJC5>3.0.CO;2-8","article-title":"Alterations of the p53 tumor-suppressor gene and K-ras oncogene in perihilar cholangiocarcinomas from a high-incidence area","volume":"78","author":"PD Sturm","year":"1998","journal-title":"International journal of cancer Journal international du cancer"},{"key":"ref26","first-page":"1121","article-title":"Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing","volume":"50","author":"M Tada","year":"1990","journal-title":"Cancer research"},{"key":"ref27","first-page":"811","article-title":"[Detection of ras gene mutations of primary hepatic malignant tumors by polymerase chain reaction and direct sequencing method]","volume":"87","author":"M Tada","year":"1990","journal-title":"Nihon Shokakibyo Gakkai zasshi\u200a=\u200aThe Japanese journal of gastro-enterology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/cncr.2820690509","article-title":"High incidence of ras gene mutation in intrahepatic cholangiocarcinoma","volume":"69","author":"M Tada","year":"1992","journal-title":"Cancer"},{"key":"ref29","first-page":"316","article-title":"The incidence of K-ras codon 12 mutations in cholangiocarcinoma detected by polymerase chain reaction technique","volume":"81","author":"S Wattanasirichaigoon","year":"1998","journal-title":"Journal of the Medical Association of Thailand\u200a=\u200aChotmaihet thangphaet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0168-8278(00)80386-4","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development","volume":"32","author":"KM Boberg","year":"2000","journal-title":"Journal of hepatology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1023\/A:1005412626515","article-title":"Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver","volume":"45","author":"A Tannapfel","year":"2000","journal-title":"Digestive diseases and sciences"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1046\/j.1365-2362.2000.00717.x","article-title":"New p53 mutations in hilar cholangiocarcinoma","volume":"30","author":"A Tullo","year":"2000","journal-title":"European journal of clinical investigation"},{"key":"ref33","first-page":"1124","article-title":"Mutations of the DPC4\/Smad4 gene in biliary tract carcinoma","volume":"58","author":"SA Hahn","year":"1998","journal-title":"Cancer research"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1158\/1078-0432.CCR-1121-3","article-title":"Missense mutations of MADH4: characterization of the mutational hot spot and functional consequences in human tumors","volume":"10","author":"CA Iacobuzio-Donahue","year":"2004","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/jsre.1999.5615","article-title":"Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma","volume":"84","author":"SA Ahrendt","year":"1999","journal-title":"The Journal of surgical research"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.3748\/wjg.v13.i47.6396","article-title":"Two distinct pathways of p16 gene inactivation in gallbladder cancer","volume":"13","author":"H Tadokoro","year":"2007","journal-title":"World journal of gastroenterology : WJG"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1053\/gast.2002.36021","article-title":"p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma","volume":"123","author":"M Taniai","year":"2002","journal-title":"Gastroenterology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.47.5.721","article-title":"Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver","volume":"47","author":"A Tannapfel","year":"2000","journal-title":"Gut"},{"key":"ref39","first-page":"2756","article-title":"Mutations of p16Ink4\/CDKN2 and p15Ink4B\/MTS2 genes in biliary tract cancers","volume":"55","author":"S Yoshida","year":"1995","journal-title":"Cancer research"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1634\/theoncologist.2011-0386","article-title":"Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping","volume":"17","author":"DR Borger","year":"2012","journal-title":"The oncologist"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.humpath.2011.12.007","article-title":"Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma","volume":"43","author":"BR Kipp","year":"2012","journal-title":"Human pathology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e15640","DOI":"10.1371\/journal.pone.0015640","article-title":"Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma","volume":"6","author":"TL Gu","year":"2011","journal-title":"PloS one"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00432-005-0016-1","article-title":"Detection of response-predicting mutations in the kinase domain of the epidermal growth factor receptor gene in cholangiocarcinomas","volume":"131","author":"GY Gwak","year":"2005","journal-title":"Journal of cancer research and clinical oncology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1158\/1078-0432.CCR-05-1692","article-title":"Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma","volume":"12","author":"F Leone","year":"2006","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/gut.52.5.706","article-title":"Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma","volume":"52","author":"A Tannapfel","year":"2003","journal-title":"Gut"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2407-11-60","article-title":"Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma","volume":"11","author":"V Deshpande","year":"2011","journal-title":"BMC cancer"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/gcc.20540","article-title":"Rare PIK3CA hotspot mutations in carcinomas of the biliary tract","volume":"47","author":"MO Riener","year":"2008","journal-title":"Genes, chromosomes & cancer"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00428-012-1202-6","article-title":"Aspects of liver pathology in adult patients with MDR3\/ABCB4 gene mutations","volume":"460","author":"D Wendum","year":"2012","journal-title":"Virchows Archiv : an international journal of pathology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpeds.2007.02.030","article-title":"Mutations in bile salt export pump (ABCB11) in two children with progressive familial intrahepatic cholestasis and cholangiocarcinoma","volume":"150","author":"AO Scheimann","year":"2007","journal-title":"The Journal of pediatrics"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1053\/j.gastro.2008.01.038","article-title":"Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families","volume":"134","author":"SS Strautnieks","year":"2008","journal-title":"Gastroenterology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH816>3.0.CO;2-K","article-title":"E-cadherin gene mutations in human intrahepatic cholangiocarcinoma","volume":"193","author":"K Endo","year":"2001","journal-title":"The Journal of pathology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0168-8278(02)00057-0","article-title":"Gene amplification and mRNA and protein overexpression of c-erbB-2 (HER-2\/neu) in human intrahepatic cholangiocarcinoma as detected by fluorescence in situ hybridization, in situ hybridization, and immunohistochemistry","volume":"36","author":"Y Ukita","year":"2002","journal-title":"Journal of hepatology"},{"key":"ref53","article-title":"FGFR2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma","volume":"2013 Oct 9","author":"Y Arai","year":"2013","journal-title":"Hepatology"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1158\/2159-8290.CD-13-0050","article-title":"Identification of targetable FGFR gene fusions in diverse cancers","volume":"3","author":"YM Wu","year":"2013","journal-title":"Cancer Discov"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1101\/gr.176601","article-title":"Predicting deleterious amino acid substitutions","volume":"11","author":"PC Ng","year":"2001","journal-title":"Genome Res"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"IA Adzhubei","year":"2010","journal-title":"Nat Methods"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"R232","DOI":"10.1186\/gb-2007-8-11-r232","article-title":"Determinants of protein function revealed by combinatorial entropy optimization","volume":"8","author":"B Reva","year":"2007","journal-title":"Genome Biol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nmeth0810-575","article-title":"MutationTaster evaluates disease-causing potential of sequence alterations","volume":"7","author":"JM Schwarz","year":"2010","journal-title":"Nat Methods"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1158\/1535-7163.MCT-12-0781","article-title":"Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities","volume":"12","author":"DW Craig","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrm2142","article-title":"Netrins: beyond the brain","volume":"8","author":"V Cirulli","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nm846","article-title":"A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2","volume":"9","author":"JH Qi","year":"2003","journal-title":"Nat Med"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/B978-0-12-386503-8.00002-8","article-title":"Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis","volume":"114","author":"O Salvucci","year":"2012","journal-title":"Adv Cancer Res"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nrc1276","article-title":"Cell adhesion and signalling by cadherins and Ig-CAMs in cancer","volume":"4","author":"U Cavallaro","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/humu.21610","article-title":"Two mutations in human BICC1 resulting in Wnt pathway hyperactivity associated with cystic renal dysplasia","volume":"33","author":"MR Kraus","year":"2012","journal-title":"Hum Mutat"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/jnci\/djq343","article-title":"CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer","volume":"102","author":"X Wang","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10238-011-0138-5","article-title":"Gene expression of O-GlcNAc cycling enzymes in human breast cancers","volume":"12","author":"A Krzeslak","year":"2012","journal-title":"Clin Exp Med"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/gcc.20897","article-title":"Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor","volume":"50","author":"CR Antonescu","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/path.2513","article-title":"Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions","volume":"217","author":"KH Hallor","year":"2009","journal-title":"J Pathol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/sj.bjc.6605366","article-title":"Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors","volume":"101","author":"R Kumar","year":"2009","journal-title":"Br J Cancer"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2013.01.013","article-title":"TACC3 promotes epithelial-mesenchymal transition (EMT) through the activation of PI3K\/Akt and ERK signaling pathways","volume":"332","author":"GH Ha","year":"2013","journal-title":"Cancer Lett"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: from development to cancer","volume":"10","author":"N Turner","year":"2010","journal-title":"Nature reviews Cancer"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/hmg\/dds486","article-title":"Oncogenic FGFR3 gene fusions in bladder cancer. Human molecular genetics","volume":"22","author":"SV Williams","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/blood-2003-12-4290","article-title":"Transforming property of TEL-FGFR3 mediated through PI3-K in a T-cell lymphoma that subsequently progressed to AML","volume":"105","author":"T Maeda","year":"2005","journal-title":"Blood"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1158\/0008-5472.CAN-11-1109","article-title":"Src activation plays an important key role in lymphomagenesis induced by FGFR1 fusion kinases","volume":"71","author":"M Ren","year":"2011","journal-title":"Cancer research"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Ren M, Qin H, Ren R, Cowell JK (2012) Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities. Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, UK.","DOI":"10.1038\/leu.2012.188"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1182\/blood.V90.10.4062","article-title":"A novel chromosomal translocation t(4; 14)(p16.3; q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene","volume":"90","author":"R Richelda","year":"1997","journal-title":"Blood"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000140631","article-title":"Fibroblast growth factor receptor and platelet-derived growth factor receptor abnormalities in eosinophilic myeloproliferative disorders","volume":"119","author":"NC Cross","year":"2008","journal-title":"Acta haematologica"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1126\/science.1220834","article-title":"Transforming fusions of FGFR and TACC genes in human glioblastoma","volume":"337","author":"D Singh","year":"2012","journal-title":"Science"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1038\/onc.2012.315","article-title":"Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas","volume":"32","author":"P Wang","year":"2012","journal-title":"Oncogene"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1242\/dev.038174","article-title":"Bicaudal C, a novel regulator of Dvl signaling abutting RNA-processing bodies, controls cilia orientation and leftward flow","volume":"136","author":"C Maisonneuve","year":"2009","journal-title":"Development"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1242\/dev.00788","article-title":"A crucial role for Fgfr2-IIIb signalling in epidermal development and hair follicle patterning","volume":"130","author":"A Petiot","year":"2003","journal-title":"Development"},{"key":"ref82","first-page":"5369","article-title":"Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells","volume":"57","author":"S Feng","year":"1997","journal-title":"Cancer Res"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"7234","DOI":"10.1038\/sj.onc.1203186","article-title":"Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer","volume":"18","author":"D Ricol","year":"1999","journal-title":"Oncogene"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/sj.onc.1201242","article-title":"Ligand-independent activation of fibroblast growth factor receptor-2 by carboxyl terminal alterations","volume":"15","author":"MV Lorenzi","year":"1997","journal-title":"Oncogene"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1182\/blood-2007-02-074286","article-title":"Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome","volume":"110","author":"A Chase","year":"2007","journal-title":"Blood"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1158\/2159-8290.CD-12-0210","article-title":"FGFR Genetic Alterations Predict for Sensitivity to NVP-BGJ398, a Selective Pan-FGFR Inhibitor","volume":"2","author":"V Guagnano","year":"2012","journal-title":"Cancer discovery"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1158\/1535-7163.MCT-11-0450","article-title":"Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models","volume":"11","author":"JM Gozgit","year":"2012","journal-title":"Molecular cancer therapeutics"},{"key":"ref88","first-page":"4115","article-title":"Significance of keratinocyte growth factor receptor in the proliferation of biliary tract cancer","volume":"30","author":"R Amano","year":"2010","journal-title":"Anticancer Res"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1158\/1535-7163.MCT-07-0193","article-title":"Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity","volume":"6","author":"R Kumar","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.embor.7400458","article-title":"Targeted expression of RALT in mouse skin inhibits epidermal growth factor receptor signalling and generates a Waved-like phenotype","volume":"6","author":"C Ballaro","year":"2005","journal-title":"EMBO reports"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nm1401","article-title":"Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation","volume":"12","author":"I Ferby","year":"2006","journal-title":"Nature medicine"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.1073\/pnas.0903632106","article-title":"Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease","volume":"106","author":"JW Jeong","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"E554","DOI":"10.1210\/jc.2010-1800","article-title":"Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer","volume":"96","author":"CI Lin","year":"2011","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/hep.23428","article-title":"Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma","volume":"51","author":"M Reschke","year":"2010","journal-title":"Hepatology"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1038\/sj.onc.1206516","article-title":"Feedback inhibition by RALT controls signal output by the ErbB network","volume":"22","author":"S Anastasi","year":"2003","journal-title":"Oncogene"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nature05998","article-title":"Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface","volume":"450","author":"X Zhang","year":"2007","journal-title":"Nature"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1083\/jcb.201002032","article-title":"A two-tiered mechanism of EGFR inhibition by RALT\/MIG6 via kinase suppression and receptor degradation","volume":"189","author":"Y Frosi","year":"2010","journal-title":"The Journal of cell biology"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1038\/sj.onc.1208658","article-title":"Loss of RALT\/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin","volume":"24","author":"S Anastasi","year":"2005","journal-title":"Oncogene"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"265","DOI":"10.18632\/oncotarget.137","article-title":"Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes","volume":"1","author":"CG Duncan","year":"2010","journal-title":"Oncotarget"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1073\/pnas.0914930107","article-title":"Mig-6 controls EGFR trafficking and suppresses gliomagenesis","volume":"107","author":"H Ying","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/mc.20815","article-title":"Downregulation of Mig-6 in nonsmall-cell lung cancer is associated with EGFR signaling","volume":"51","author":"Z Li","year":"2012","journal-title":"Molecular carcinogenesis"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"e38955","DOI":"10.1371\/journal.pone.0038955","article-title":"Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation","volume":"7","author":"YW Zhang","year":"2012","journal-title":"PloS one"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.onc.1209790","article-title":"Evidence that MIG-6 is a tumor-suppressor gene","volume":"26","author":"YW Zhang","year":"2007","journal-title":"Oncogene"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"7630","DOI":"10.1158\/0008-5472.CAN-10-1489","article-title":"GP369, an FGFR2-IIIb-specific antibody, exhibits potent antitumor activity against human cancers driven by activated FGFR2 signaling","volume":"70","author":"A Bai","year":"2010","journal-title":"Cancer Res"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/1471-2164-14-302","article-title":"Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs","volume":"14","author":"A Christoforides","year":"2013","journal-title":"BMC Genomics"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/gb-2011-12-8-r72","article-title":"TopHat-Fusion: an algorithm for discovery of novel fusion transcripts","volume":"12","author":"D Kim","year":"2011","journal-title":"Genome Biol"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1093\/bioinformatics\/btr467","article-title":"ChimeraScan: a tool for identifying chimeric transcription in sequencing data","volume":"27","author":"MK Iyer","year":"2011","journal-title":"Bioinformatics"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"e1001138","DOI":"10.1371\/journal.pcbi.1001138","article-title":"deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data","volume":"7","author":"A McPherson","year":"2011","journal-title":"PLoS Comput Biol"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1093\/nar\/gkr362","article-title":"A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines","volume":"39","author":"YW Asmann","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"e32783","DOI":"10.1371\/journal.pone.0032783","article-title":"Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells","volume":"7","author":"CH Diep","year":"2012","journal-title":"PLoS One"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/ng.2273","article-title":"Exome sequencing of liver fluke-associated cholangiocarcinoma","volume":"44","author":"CK Ong","year":"2012","journal-title":"Nature genetics"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature11547","article-title":"Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes","volume":"491","author":"AV Biankin","year":"2012","journal-title":"Nature"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ng.2256","article-title":"Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma","volume":"44","author":"C Guichard","year":"2012","journal-title":"Nature genetics"}],"container-title":["PLoS Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pgen.1004135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T10:35:33Z","timestamp":1597487733000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgen.1004135"}},"subtitle":[],"editor":[{"given":"Marshall S.","family":"Horwitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,13]]},"references-count":113,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgen.1004135","relation":{},"ISSN":["1553-7404"],"issn-type":[{"value":"1553-7404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,13]]}}}